Medicinal Products

Palexia retard 250 mg tablete s produljenim oslobađanjem

Name Palexia retard 250 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-710842589
Active Substance tapentadolklorid
Composition jedna tableta s produljenim oslobađanjem sadrži 250 mg tapentadola (u obliku tapentadolklorida)
Pharmaceutical Form tableta s produljenim oslobađanjem
Manufacturer Grünenthal GmbH, Aachen, Njemačka
Marketing Authorisation Holder Grünenthal GmbH, Zieglerstraße 6, Aachen, Njemačka
Marketing Authorisation Date 27.07.2015
MA Period of Validity unlimited
Classification Number UP/I-530-09/14-02/428
Registration Number 381-12-01/30-15-07
Prescription Medicinal product subject to medical prescription
Type of prescription poseban recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code N02AX06
Marketing status nije stavljeno u promet
SmPC download
PL download
Public Assessment Report download

Packaging

Back

For Patients and Public

For Health Care Professionals

For Industry Representatives